Literature DB >> 2899326

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

G Di Chiara1, A Imperato.   

Abstract

The effect of various drugs on the extracellular concentration of dopamine in two terminal dopaminergic areas, the nucleus accumbens septi (a limbic area) and the dorsal caudate nucleus (a subcortical motor area), was studied in freely moving rats by using brain dialysis. Drugs abused by humans (e.g., opiates, ethanol, nicotine, amphetamine, and cocaine) increased extracellular dopamine concentrations in both areas, but especially in the accumbens, and elicited hypermotility at low doses. On the other hand, drugs with aversive properties (e.g., agonists of kappa opioid receptors, U-50,488, tifluadom, and bremazocine) reduced dopamine release in the accumbens and in the caudate and elicited hypomotility. Haloperidol, a neuroleptic drug, increased extracellular dopamine concentrations, but this effect was not preferential for the accumbens and was associated with hypomotility and sedation. Drugs not abused by humans [e.g., imipramine (an antidepressant), atropine (an antimuscarinic drug), and diphenhydramine (an antihistamine)] failed to modify synaptic dopamine concentrations. These results provide biochemical evidence for the hypothesis that stimulation of dopamine transmission in the limbic system might be a fundamental property of drugs that are abused.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899326      PMCID: PMC281732          DOI: 10.1073/pnas.85.14.5274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

2.  Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats.

Authors:  H O Pettit; A Ettenberg; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats.

Authors:  G Mereu; F Fadda; G L Gessa
Journal:  Brain Res       Date:  1984-01-30       Impact factor: 3.252

4.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

Authors:  A Imperato; G Di Chiara
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

5.  Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine.

Authors:  R T Matthews; D C German
Journal:  Neuroscience       Date:  1984-03       Impact factor: 3.590

6.  In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

Authors:  T Zetterström; T Sharp; C A Marsden; U Ungerstedt
Journal:  J Neurochem       Date:  1983-12       Impact factor: 5.372

7.  Dopaminergic substrates of amphetamine-induced place preference conditioning.

Authors:  C Spyraki; H C Fibiger; A G Phillips
Journal:  Brain Res       Date:  1982-12-16       Impact factor: 3.252

8.  Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.

Authors:  W B Mackey; D van der Kooy
Journal:  Pharmacol Biochem Behav       Date:  1985-01       Impact factor: 3.533

9.  Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.

Authors:  A Imperato; G Di Chiara
Journal:  J Neurosci       Date:  1985-02       Impact factor: 6.167

10.  Pharmacologic characterization of nicotine-induced conditioned place preference.

Authors:  P J Fudala; K W Teoh; E T Iwamoto
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

View more
  1303 in total

Review 1.  Recent advances in the biology of addiction.

Authors:  S E Hemby
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.

Authors:  F C Dalman; K L O'Malley
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

3.  Dopamine receptor imaging in alcohol dependency: should personality traits be taken into account?

Authors:  I Goethals; C Van De Wiele; K Audenaert
Journal:  Eur J Nucl Med       Date:  2001-11

4.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 5.  Neural systems underlying opiate addiction.

Authors:  Taco J De Vries; Toni S Shippenberg
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 6.  Vaccines against nicotine: how effective are they likely to be in preventing smoking?

Authors:  F J Vocci; C N Chiang
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens.

Authors:  T Hikida; S Kaneko; T Isobe; Y Kitabatake; D Watanabe; I Pastan; S Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

8.  Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

Authors:  Mark A Smith; Keith A Gordon; Christopher K Craig; Paul A Bryant; M Eric Ferguson; Adam M French; Jason D Gray; Jacob M McClean; Jonathan C Tetirick
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

9.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

10.  A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.

Authors:  Nurulain T Zaveri; Paul V Marquez; Michael E Meyer; Willma E Polgar; Abdul Hamid; Kabirullah Lutfy
Journal:  Alcohol Clin Exp Res       Date:  2018-01-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.